This paper is in the following e-collection/theme issue:
RCTs - Protocols/Proposals (eHealth) (443) Obstetrics, Gynecology, and Reproductive Medicine (153) Pregnancy Information, Education and Lifestyle Interventions (235)Published on in Vol 11 , No 10 (2022) :October
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/37452, first published
.

The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial
The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial
Authors of this article:
Pablo Garcia-Manau 1








































There are no citations yet available for this article according to Crossref .